Russell Investments Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Russell Investments Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,125	Closed	-$968K	–	3145
2018 Q3	$968K	Sell	12,125 -6,418	-35%	-$598K	﹤0.01%	2124
2018 Q2	$1.79M	Sell	18,543 -16,043	-46%	-$1.39M	﹤0.01%	1816
2018 Q1	$2.8M	Hold	34,586	–	–	﹤0.01%	1644
2017 Q4	$2.73M	Hold	34,586	–	–	﹤0.01%	1668
2017 Q3	$3.19M	Sell	34,586 -10,855	-24%	-$1.04M	0.01%	1515
2017 Q2	$5.14M	Sell	45,441 -7,116	-14%	-$795K	0.01%	1223
2017 Q1	$5.26M	Sell	52,557 -1,829	-3%	-$195K	0.01%	1185
2016 Q4	$5.87M	Buy	+54,386	New	+$6.36M	0.01%	1134

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's CBPO Position: Q4 2018 in Review

Russell Investments Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 12,125 shares — an estimated $968K sold.

Russell Investments Group first reported a position in CBPO in Q4 2016 and held it in 8 quarters. The position peaked at $5.87M in Q4 2016. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

Russell Investments Group reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
Russell Investments Group sold 12,125 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $968K.
Russell Investments Group first reported a position in China Biologic Products Holdings, Inc. in Q4 2016 and held it in 8 quarters.
Russell Investments Group's China Biologic Products Holdings, Inc. position peaked at $5.87M in Q4 2016.
67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Russell Investments Group's 13F filing for Q4 2018, filed 11 Feb 2019.